medigraphic.com
ISSN 1560-4381 (Print)

2017, Number 2

<< Back Next >>

Correo Científico Médico 2017; 21 (2)

Community strategy of primary prevention and early diagnosis of Usher syndrome in Holguin province

Santana HEE, Lantigua CPA, Silva VE, Godoy MK, Leyva TM, Feria RM

Language: Spanish
References: 14
Page: 423-433
PDF size: 336.70 Kb.


ABSTRACT

Introduction: Usher syndrome is a genetically determined disease with great clinical and genetic heterogeneity. It is characterized by sensorineural hearing loss from mild to severe, progressive retinitis pigmentosa and may be accompanied by alterations in the vestibular function. Because of its high prevalence in Holguin and significant visual and hearing impairment, a preventive and diagnostic tool is necessary.
Objective: propose a Community strategy for primary prevention in these families and early diagnosis of this genetic condition. Characterize all clinically affected and describe the evolutionary characteristics.
Method: a series of cases descriptive study was carried out in 53 patients with a clinical diagnosis of Usher Syndrome, who are treated at the Provincial Center for Pigmentary Retinosis of Holguín province from February 2009 to December 2015. Clinical records, collecting in an instrument designed for the study all the data of interest that allowed to characterize the universe of study and to determine the variables susceptible of analysis.
Results: clinical characterization of 100% of the patients studied was achieved. 80% had retinitis pigmentosa in early childhood. Of them, 33 affected patients are involved in consanguineous families for 62.26%, there were 17 consanguineous families for 44.73% and outbred 21 for a 55.26%.
Conclusions: this community strategy that will help in primary care to undertake primary prevention in families of patients and early diagnosis allowing those affected to provide appropriate genetic counseling to these families is proposed.


REFERENCES

  1. Sadeghi AM, Cohn ES, Kimberling WJ, Halvarsson G, Möller C. Expressivity of hearing loss in cases with Usher syndrome type IIA. Int J Audiol. 2013[citado 11 feb 2014];52(12):832-837. Disponible en: http://www.tandfonline.com/doi/full/10.3109/14992027.2013.839885

  2. Boo SH, Song MJ, Kim HJ, Cho YS, Chu H, Ko MH, et al. A Novel Frameshift Mutation of the USH2A Gene in a Korean Patient with Usher Syndrome Type II. Clin Exp Otorhinolaryngol. 2013[citado 3 ene 2014];6(1):41-44. Disponible en: http://www.e-ceo.org/journal/view.php?number=266

  3. Praharaj SK, Acharya M, Sarvanan A, Kongasseri S, Behere RV, Sharma PS. Mania associated with Usher syndrome type II. Turk Psikiyatri Derg. 2012[citado 8 ene 2014] 23(3):219-221. Disponible en: http://eprints.manipal.edu/136489/

  4. López G, Gelvez NY, Tamayo M. Frecuencia de mutaciones en el gen de la usherina (USH2A) en 26 individuos colombianos con síndrome de Usher, tipo II. Biomédica. 2011[citado 12 mar 2012];31(1):82-90. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-41572011000100010&lng=pt&nrm=iso&tlng=es

  5. Wang L, Zou J, Shen Z, Song E, Yang J. Whirlin interacts with espin and modulates its actin-regulatory function: an insight into the mechanism of Usher syndrome type II. Hum Mol Genet. 2012[citado 12 mar 2013];21(3):692-710. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259019/

  6. García García G, Aparisi MJ, Jaijo T, Rodrigo R, Léon AM, Avila Fernandez A. Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations. Orphanet J Rare Dis. 2011 [citado 12 mar 2012];6:65. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207874/

  7. Tamayo ML, Lopez G, Gelvez N, Medina D, Kimberling WJ, Rodríguez V, et al. Genetic counseling in Usher syndrome: linkage and mutational analysis of 10 Colombian families. Genet Couns. 2008 [citado 12 mar 2012];19(1):15-27. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/18564497

  8. Lenassi E, Saihan Z, Bitner Glindzicz M, Webster AR. The effect of the common c.2299delG mutation in USH2A on RNA splicing. Exp Eye Res. 2014;122:9-12. Disponible en: http://www.sciencedirect.com/science/article/pii/S0014483514000621

  9. Aller E, Larrieu L, Jaijo T, Baux D, Espinós C, González Candelas F. The USH2A c.2299delG mutation: dating its common origin in a Southern European population. Eur J Hum Genet. 2010[citado 8 ene 2014];18(7):788-793. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987359/

  10. Yan D, Ouyang X, Patterson DM, Du LL, Jacobson SG, Liu XZ. Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type II. J Hum Genet. 2009 [citado 8 ene 2014];54(12):732-738. Disponible en: http://www.nature.com/jhg/journal/v54/n12/abs/jhg2009107a.html

  11. Dreyer B, Tranebjaerg L, Rosenberg T, Weston MD, Kimberling WJ, Nilssen O. Identification of novel USH2A mutations: implications for the structure of USH2A protein. Eur J Hum Genet. 2000 [citado 8 ene 2014];8(7):500-506. Disponible en: http://www.nature.com/ejhg/journal/v8/n7/abs/5200491a.html

  12. Ouyang XM, Hejtmancik JF, Jacobson SG, Li AR, Du LL, Angeli S, et al. Mutational spectrum in Usher syndrome type II. Clin Genet. 2004[citado 8 ene 2014]; 65(4):288-293.Disponible en: http://onlinelibrary.wiley.com/doi/10.1046/j.1399-0004.2004.00216.x/full

  13. Dreyer B, Tranebjaerg L, Brox V, Rosenberg T, Möller C, Beneyto M, et al. A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. Am J Hum Genet. 2001[citado 8 ene 2014];69(1):228-34.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1226039/

  14. Aller E, Nájera C, Millán JM, Oltra JS, Pérez-Garrigues H, Vilela C. Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairments. Eur J Hum Genet. 2004 [citado 8 ene 2014];12(5):407-410. Disponible en: http://www.nature.com/ejhg/journal/v12/n5/abs/5201138a.html




2020     |     www.medigraphic.com